With over 17 years of experience as a director in the Vodafone Group, I have developed a deep expertise in establishing and leading enterprise businesses across emerging markets and the USA. I have successfully delivered innovative solutions, strategic partnerships, and customer-centric services that enhanced the brand value and market share of Vodafone in the global telecommunications industry.Currently, I leverage my extensive knowledge and network in the biotechnology sector as a Non-Executive Director and Advisor M&A at Pivotal Scientific, a leading biotechnology consultancy that helps companies grow sales and brand awareness. I support the business at all stages of the life cycle, from product development to market entry, and provide guidance on mergers and acquisitions, commercialization, and innovation. I also serve as a board advisor for several biotechnology companies, including 2BScientific, Absolute Antibody, and Trak Global Group, where I contribute to their strategic vision, growth plans, and operational excellence.